Nephros (NEPH) Cash & Equivalents Growth (3y) (2013 - 2026)
Nephros (NEPH) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -7.03% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -25.69% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 21.08% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 93.87% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -18.20% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 7.45% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 8.39% |
| 10 | Nephros | 36.20 Mn | 32.18 Mn | 2.99 Mn | 1.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.56% |
| Dec 31, 2025 | 14.11% |
| Sep 30, 2025 | 9.49% |
| Jun 30, 2025 | 6.68% |
| Mar 31, 2025 | -9.03% |
| Dec 31, 2024 | -18.61% |
| Sep 30, 2024 | -30.60% |
| Jun 30, 2024 | -28.08% |
| Mar 31, 2024 | -23.65% |
| Dec 31, 2023 | -19.48% |
| Sep 30, 2023 | -3.57% |
| Jun 30, 2023 | -16.79% |
| Mar 31, 2023 | -24.64% |
| Dec 31, 2022 | -4.45% |
| Sep 30, 2022 | 0.73% |
| Jun 30, 2022 | -1.08% |
| Mar 31, 2022 | 14.53% |
| Dec 31, 2021 | 15.03% |
| Sep 30, 2021 | 11.36% |
| Jun 30, 2021 | 33.44% |